Wright Medical Group N.V. reported unaudited consolidated earnings results for the first quarter ended April 1, 2018. For the quarter, the company reported net sales of $198,537,000 against $177,191,000 a year ago. Operating loss was $890,000 against $9,598,000 a year ago. Loss from continuing operations before income taxes was $19,702,000 against $35,768,000 a year ago. Net loss from continuing operations was $19,907,000 or $0.19 per basic and diluted share against $36,707,000 or $0.35 per basic and diluted share a year ago. Net loss was $25,514,000 or $0.24 per basic and diluted share against $58,699,000 or $0.57 per basic and diluted share a year ago. Non-GAAP net loss from continuing operations, as adjusted was $8,248,000 against $16,229,000 a year ago. Adjusted non-GAAP earnings were $1,107,000 against $8,832,000 a year ago. Adjusted non-GAAP earnings per share were $0.01 against $0.09 a year ago. Non-GAAP EBITDA was $21,750,000 against $3,270,000 a year ago. Non-GAAP adjusted EBITDA was $26,678,000 against $18,171,000 a year ago.

The company continues to anticipate net sales for full-year 2018 of approximately $800 million to $812 million. Non-GAAP adjusted EBITDA from continuing operations to be in the range of $104 million to $111 million. Non-GAAP adjusted earnings per share from continuing operations, including share-based compensation for full-year 2018 to be a loss of $0.16 to $0.23 per diluted share.